Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Medical staff who helped during the Westminster terror attack have received a royal thanks for their life-saving efforts.
Colin Gregg, the son of the founder of the Greggs bakers chain, has been jailed at Newcastle Crown Court for 13 and a half years.
Khalid Masood was killed by a single gunshot to his chest, after the terror attack which claimed the lives of four people, an inquest heard.